GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioVaxys Technology Corp (OTCPK:BVAXF) » Definitions » Shares Buyback Ratio %

BioVaxys Technology (BioVaxys Technology) Shares Buyback Ratio % : -48.01 (As of Jun. 01, 2024)


View and export this data going back to 2018. Start your Free Trial

What is BioVaxys Technology Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. BioVaxys Technology's current shares buyback ratio was -48.01%.


BioVaxys Technology Shares Buyback Ratio % Historical Data

The historical data trend for BioVaxys Technology's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioVaxys Technology Shares Buyback Ratio % Chart

BioVaxys Technology Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Oct22
Shares Buyback Ratio %
- - -245.26 -24.45 -18.04

BioVaxys Technology Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.33 -10.99 -5.71 -28.68 1.96

BioVaxys Technology Shares Buyback Ratio % Calculation

BioVaxys Technology's Shares Buyback Ratio for the fiscal year that ended in Oct. 2022 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Oct. 2021 ) - Shares Outstanding (EOP) (A: Oct. 2022 )) / Shares Outstanding (EOP) (A: Oct. 2021 )
=(92.187 - 108.813) / 92.187
=-18.04%

BioVaxys Technology's Shares Buyback Ratio for the quarter that ended in Jul. 2023 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Apr. 2023 ) - Shares Outstanding (EOP) (A: Jul. 2023 )) / Shares Outstanding (EOP) (A: Apr. 2023 )
=(148.014 - 145.112) / 148.014
=1.96%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioVaxys Technology Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of BioVaxys Technology's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


BioVaxys Technology (BioVaxys Technology) Business Description

Traded in Other Exchanges
Address
146 Thirtieth Street, Suite 100, Etobicoke, ON, CAN, M8W 3D4
BioVaxys Technology Corp is a clinical-stage biopharma company. The company develops antiviral and anticancer vaccine platforms to treat SARS-CoV-2 and other viral infections, as well as ovarian cancer and other solid tumor types.

BioVaxys Technology (BioVaxys Technology) Headlines

From GuruFocus

BIOVAXYS ANNOUNCES WARRANT EXTENSION

By PRNewswire PRNewswire 08-10-2022